Granulomatous Disease, Chronic: Clinical Trials

2 trials for Granulomatous Disease, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow Granulomatous Disease, Chronic: new trials by email Literature Review of Granulomatous Disease, Chronic trials Research Report on Granulomatous Disease, Chronic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease
IFN-gamma - IFN-Gamma Therapy, CGD Gene Mutation
Phase 4TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)22010-05-182017-09-20
A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood
interferon-gamma - Chronic Granulomatous Disease
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1001992-05-012008-03-04

Narrower conditions

Immunologic Deficiency Syndromes (1)  ·  Infections (1)

Broader conditions

Chronic Disease (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disease Attributes (2)  ·  Genetic Diseases, Inborn (2)  ·  Genetic Diseases, X-Linked (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Leukocyte Disorders (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Phagocyte Bactericidal Dysfunction (2)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Interferon-gamma (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)

Countries

United States (2)

Top investigators

John I Gallin, M.D. (1)